Since our collagen-induced arthritis model is different from the Il1rn-dependent model in which polyarthritis develops spontaneously [43], it is difficult to compare directly which therapeutic method, anti-IL-17A or anti-CXCR2 is more effective. This evidence concerns the gene IL17A and arthritic joint disease.